An Open Multi-centre Phase III Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients Under the Age of 6 Years
Latest Information Update: 09 May 2019
At a glance
- Drugs Factor IX (Primary)
- Indications Haemophilia B
- Focus Therapeutic Use
- Sponsors Bio Products Laboratory
Most Recent Events
- 17 Oct 2014 New trial record